Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:01 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 320 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Abbott Medical Devices Clear all

Conditions: Angioplasty, Chronic Coronary Occlusion, Stent Thrombosis, Vascular Disease, Myocardial Ischemia, Coronary Artery Stenosis, Coronary Disease, Coronary Artery Disease, Coronary Restenosis
Interventions: XIENCE V® Everolimus Eluting Coronary Stent System (EECSS); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: Not listed
Enrollment: 2,605 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Santa Clara, California

Conditions: Typical Atrial Flutter
Interventions: Treatment Arm; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 19
States / cities: Birmingham, Alabama • Denver, Colorado • Hartford, Connecticut + 15 more

Conditions: Mitral Regurgitation, Mitral Valve Regurgitation
Interventions: MitraClip® NT System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 32
States / cities: La Jolla, California • Los Angeles, California • Mountain View, California + 25 more

Conditions: Heart Failure
Interventions: LVAD Implant, Aspirin 100mg, Placebo oral tablet; Device · Drug
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 628 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 41
States / cities: Little Rock, Arkansas • La Jolla, California • Palo Alto, California + 31 more

Conditions: Paroxysmal Atrial Fibrillation
Interventions: SJM Irrigated Cardiac Ablation System, FDA approved Open Irrigated RF Ablation System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 27
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 22 more

Conditions: Mitral Valve Insufficiency, Mitral Valve Regurgitation, Mitral Valve Incompetence, Mitral Regurgitation, Mitral Insufficiency
Interventions: Percutaneous mitral valve repair (MitraClip Implant); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Sudden Cardiac Death
Interventions: Cardiac Resynchronization Therapy - Defibrillator (CRT-D); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Santa Monica, California • Colorado Springs, Colorado

Conditions: Heart Failure, Cardiac Output
Interventions: MRI/ CardioMEMS comparison; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 8
States / cities: Augusta, Georgia • Kansas City, Kansas • Southfield, Michigan + 5 more

Conditions: Coronary Artery Calcification, Coronary Artery Disease, Stenotic Coronary Lesion
Interventions: Experimental; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 335 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 40
States / cities: Scottsdale, Arizona • Little Rock, Arkansas • Los Angeles, California + 33 more

Conditions: Polycystic Ovary Syndrome
Interventions: Metformin; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Atrial Fibrillation, Stroke, Bleeding
Interventions: Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Non-Vitamin K Oral Antagonists; Device · Drug
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 2,650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2031
U.S. locations: 79
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 65 more

Conditions: Aortic Valve Insufficiency, Aortic Valve Regurgitation, Aortic Valve Stenosis, Aortic Valve Incompetence
Interventions: Trifecta™ Valve; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 9
States / cities: Los Angeles, California • Minneapolis, Minnesota • Rochester, Minnesota + 6 more

Conditions: Aortic Valve Insufficiency, Aortic Valve Regurgitation, Aortic Valve Stenosis, Aortic Valve Incompetence, Mitral Valve Insufficiency, Mitral Valve Regurgitation, Mitral Valve Stenosis, Mitral Valve Incompetence
Interventions: Biocor and Biocor Supra valves; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 297 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 17
States / cities: La Jolla, California • Los Angeles, California • Evansville, Indiana + 14 more

Conditions: Arterial Thrombosis
Interventions: JETi lower extremity arterial thrombosis; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 21
States / cities: Scottsdale, Arizona • Little Rock, Arkansas • Los Angeles, California + 16 more

Conditions: CAD
Interventions: Diamondback 360® Coronary OAS Micro Crown; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 12
States / cities: Chandler, Arizona • Gainesville, Florida • Jupiter, Florida + 8 more

Conditions: Atrial Fibrillation, Stroke, Bleeding
Interventions: Left atrial appendage occlusion (LAAO); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 610 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 16
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Jacksonville, Florida + 13 more

Conditions: Coronary Artery Disease
Interventions: Adenosine, Contrast Media, Resting conditions; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 763 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Palo Alto, California • Oklahoma City, Oklahoma

Conditions: Heart Failure, Left Bundle-Branch Block
Interventions: Mapping and Pacing the His Bundle, Placing a guidewire in Coronary sinus for measurement of Q-LV during His Bundle pacing or, if needed, for LV pacing; Procedure
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Heart Failure
Interventions: HeartPOD™ System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 4
States / cities: La Jolla, California • Los Angeles, California • Columbus, Ohio + 1 more

Conditions: Treatment Resistant Depression
Interventions: Sham-stimulation, Active-stimulation; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 22 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 26
States / cities: Birmingham, Alabama • Los Angeles, California • Sacramento, California + 19 more

Conditions: Shock
Interventions: ICD/ CRT-D; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 1,670 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Coronary Artery Disease
Interventions: Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 2,258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 97
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mesa, Arizona + 85 more

Conditions: Chronic Knee Pain, Osteoarthritis, Knee
Interventions: Nerve Block with Radiofrequency Ablation, Nerve Block with Sham Radiofrequency Ablation; Procedure
Lead sponsor: Randall Brewer, MD, CPI; Other
Eligibility: 50 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Shreveport, Louisiana

Conditions: Chronic Coronary Occlusion, Unprotected Left Main Coronary Artery Disease, Stent Thrombosis, Vascular Disease, Myocardial Ischemia, Coronary Artery Stenosis, Coronary Disease, Coronary Artery Disease, Coronary Restenosis
Interventions: Percutaneous Coronary Intervention, CABG; Device · Procedure
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 1,905 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2019
U.S. locations: 1
States / cities: Santa Clara, California

Search by objective public record fields.

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study

Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR

The ARIES HeartMate 3 Pump IDE Study

Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)

Feasibility Study of a Percutaneous Mitral Valve Repair System.

'Effect of CRT on Defibrillation Threshold Estimates' Study

Validation of CardioMEMS HF System Cardiac Output Algorithm IDE

TECTONIC CAD IVL IDE Study

Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)

Amplatzer Amulet LAAO vs. NOAC

Trifecta™ Long Term Follow-Up (LTFU) Study

Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra

JETi Lower Extremity Arterial Thrombosis

Coronary Orbital Atherectomy System Study

Amulet™ ADVANCE LAA

CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)

Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundle Branch Block

Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS)

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Radiofrequency For Chronic Knee Pain Post-Arthroplasty

EXCEL Clinical Trial